SAB BIOTHERAPEUTICS, INC. (SABSW) Shareholders’ equity 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) shareholders’ equity at each fiscal year-end, per SEC filings.
$151.5MFY2025 · since FY2020: $39.0M → $151.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $151.5M | +483.3% |
| FY2024 | $26.0M | -54.7% |
| FY2023 | $57.3M | +84.5% |
| FY2022 | $31.1M | -19.4% |
| FY2021 | $38.5M | -1.2% |
| FY2020 | $39.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating marginSABSW Operating cash flowSABSW Free cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Total liabilitiesSABSW overview →